Our new report – China’s 14th Five Year Plan: A Contender for The European Green Deal? – examines #climate, energy & industrial strategies in the latest #FiveYearPlan, and offers a lookback on climate progress in the last 5 years in the EU & China e3g.org/publications/c… (1/7)
A look back at the pace of wind and solar development in the last 5 years as #China positions renewable energy as a "strategic emerging sector" in its 14th Plan. (2/7)
The EU, while unable to compete with China on cost of manufacturing and research spending, remains more competitive on the capacity to innovate. The EU27 registers more green technology patents annually compared to China. bit.ly/3fwzdcV (3/7)
China aims to take pole position in the electric vehicle race, its current plan will see EVs make up 20% of all car sales by 2025. The EU aims to have 30m #EVs on its roads by 2030 and its CO2 standards have given the sector a much-needed boost. Who will win the race? (4/7)
Decision Time in #Peaking: While the 14th Plan is not a national strategy to decarbonise China’s economy, officials in ministries and provinces are now racing with each other to come up with ambitious decarbonisation action plans, to be published late 2021 onwards. (5/7)
The EU has made a pledge to #BuildBackBetter and European leaders have agreed to develop climate-aligned recovery plans. Beijing has placed smart infrastructure such as EVs charging points and AI as a pillar in its recovery strategy, but are they climate-aligned? (6/7)
The emphasis on self-sufficiency the 14th Plan doesn't necessarily represent an inward shift of China’s development policy. Beijing will continue the opening of the Chinese market and deepening of trade ties with its neighbours - #DualCirculation: (7/7)
• • •
Missing some Tweet in this thread? You can try to
force a refresh
If you're concerned about the coronavirus and afraid to show it because people around you say it's all a media hyperbole and you're overreacting, read this, I've got the science summarised for you (from the Lancet, Imperial College London, HKU-Harvard studies):
1) It is definitely not like the flu - on average an infected patient would infect 2.6 people (vs. 1.1-1.5 for the flu). It has a symptomatic fatality rate of 1.4%, more than 10-50 times higher than the 2009 influenza fatality rate depending on the country you’re in.
2) It only affects the elderly and people with preexisting conditions - just for a second ignore the fact that it’s such an irresponsible thing to say and as if they have no grandparents or parents, the fatality rate of people above 80 is about 6%, 4x the average rate.